• Facilitate product development and global registration by developing and executing regulatory strategies • Manage effective regulatory agency interactions for product manufacturing and quality programs throughout product lifecycle • Contribute as a member of the global regulatory CMC product team • Interact with authors/reviewers and subject matter experts with respect to delivery of regulatory documents required for regulatory submissions • Contribute to the organization and preparation of CMC investigational product amendments, post-market supplements/variations, and new marketing applications • Document and archive CMC submissions and related communications in the document management system • Initiate and maintain CMC product timelines at the direction of product lead • Interface with the regulatory operations team • Train staff on select CMC procedures and systems • Provide report status of activities and projects to teams and department • Participate in cross-functional special project teams

• Execute U.S. regulatory strategy and deliverables for assigned programs and represent the region on global teams (e.g., GRT; may include GDT/CST/LWG as applicable). • Plan and manage U.S. regulatory submissions (e.g., clinical trial and marketing applications) aligned with global filing plans and U.S. regulatory requirements. • Implement product-related regulatory tactics and activity plans in accordance with U.S. legislation, regulations, and internal standards. • Provide content guidance for key U.S. regulatory documents and meetings consistent with GRT strategy (e.g., briefing content, submission components). • Support U.S. labeling development in collaboration with the Labeling Working Group (LWG), incorporating scientific data, guidance, and precedent; support U.S. labeling negotiation activities. • Provide regulatory guidance on U.S. mechanisms and pathways to optimize development (e.g., expedited programs, orphan considerations, pediatric plans, compassionate use where applicable). • Obtain and maintain clinical trial authorizations and marketing application approvals, including support for Responses to Questions (RTQs) and other agency feedback. • Communicate regulatory strategy and expectations within the team (e.g., GRT, affiliates/stakeholders) and work with line management to assess likelihood of success, expectations, and risks. • Ensure ongoing regulatory compliance for assigned products (e.g., IMR accuracy, PMCs/commitments, pediatric and other agency obligations); escalate issues proactively. • Maintain and apply U.S. regulatory intelligence: monitor evolving legislation/guidance; research precedent and history; assess and communicate potential impact (including competitor labeling where relevant). • Support Health Authority interactions by acting as an agency contact as appropriate, documenting outcomes, and contributing to risk/contingency planning consistent with global strategy. • Partner with cross-functional teams to support alignment and execution, including U.S.-specific considerations for data use in product communications (as applicable).

• Support products in the Obesity and Related Conditions Therapeutic Area • Develop and execute regulatory strategy in close partnership with the Global Regulatory Lead (GRL) • Represent the U.S. on global teams and contribute to global regulatory and clinical development strategies • Plan and lead U.S. regulatory submissions in alignment with global filing plans and regulatory requirements • Lead development of key regulatory documents, including labels, briefing packages, and submission components aligned with product strategy • Drive U.S. labeling strategy and execution in collaboration with the Labeling Working Group • Lead Health Authority interactions for assigned products • Assess regulatory risk and likelihood of success; communicate scenarios and contingencies to the GRL, GRT, and senior management. • Ensure ongoing compliance for assigned products and proactively escalate issues

Role Description Tapestry is seeking a qualified individual to serve as Acting Chief Compliance Officer (Acting CCO) on an interim basis. The Acting CCO will assume the regulatory responsibilities of the CCO role in accordance with National Instrument 31-103 and Securities Commission requirements. This is an excellent opportunity for an experienced compliance professional to support a mission-aligned, impact-driven organization during a period of growth. - Support the registration of Tapestry as an exempt market dealer in all jurisdictions across Canada. - Establish, maintain, and oversee the Firm’s compliance policies and procedures in accordance with securities legislation and Tapestry’s Compliance Manual. - Monitor and supervise the business activities of all employees, officers, directors, and dealing representatives to ensure ongoing compliance with applicable securities laws. - Identify, escalate, and report instances of non-compliance, including any matters creating a risk of harm to clients or the capital markets, to the Ultimate Designated Person (UDP). - Oversee and manage the Firm’s compliance monitoring, testing, and reporting program, including KYC, KYP, and suitability obligations. - Ensure timely regulatory filings with the OSC and other applicable securities regulatory authorities, including anti-money laundering (AML) and anti-terrorist financing (ATF) reporting under FINTRAC requirements. - Prepare and deliver the annual compliance report to Tapestry’s Board of Directors assessing the Firm’s compliance with securities legislation. - Review, update, and recommend enhancements to the Firm’s Compliance Manual and policies as regulatory requirements or business activities evolve. - Manage and respond to client complaints in accordance with the Firm’s complaint-handling procedures, including significant complaints requiring investigation. - Identify, disclose, and oversee management of conflicts of interest, including those arising from related and connected issuers. - Liaise directly with the Board of Directors and the UDP as necessary, including providing direct and unimpeded access on compliance matters. Qualifications - In accordance with National Instrument 31-103 (section 3.10, Exempt Market Dealer – Chief Compliance Officer), candidates must satisfy one of the following proficiency pathways: - Passed the Exempt Market Products Exam or the Canadian Securities Course Exam; AND passed the Partners, Directors and Officers (PDO) Exam or the Chief Compliance Officers Qualifying Exam; AND gained 12 months of relevant securities industry experience within the 36-month period before the application; OR - Met the proficiency requirements applicable to a portfolio manager’s chief compliance officer under NI 31-103, section 3.13; OR - Qualifies for an exemption from section 3.13 under subsection 16.9(2) of NI 31-103 (registration of chief compliance officers). - Prior experience as a CCO, Deputy CCO, or senior compliance officer at a registered EMD, investment dealer, or other securities registrant. - Strong working knowledge of NI 31-103, NI 45-106, NI 33-109 and their companion policies, AML/ATF (FINTRAC) requirements, and securities commission reporting obligations. - Experience with KYC, KYP, and suitability frameworks, ideally within the exempt market or fixed-income space. - Familiarity with conflicts of interest management, particularly involving related and connected issuers. - Demonstrated ability to work independently, report to a Board of Directors, and exercise sound regulatory judgment. - Alignment with Tapestry’s mission as a non-profit, impact-driven organization is an asset. - Eligible and able to be registered with the OSC (and other applicable jurisdictions) in the category of Chief Compliance Officer. Requirements - Competitive Annual Salary: $60.46-$61.35/hour commensurate with experience. - Flexible Work Environment: Enjoy a remote-first approach with the option to work from home, our Toronto head office, or a paid membership to a co-working space in your community. - Benefits: specific benefits to be determined with the successful candidate. How to Apply Please submit a cover letter and resume in PDF and submit it to this link . In your cover letter, please address why you are interested in working for Tapestry and how you would be successful in this position. We sincerely thank you for your interest in working with us. We are a small (but mighty!) team. Thus, only those chosen for an interview will be contacted. Tapestry Community Capital is fully committed to being an equal opportunity employer and evaluating all applications without discrimination or bias. We are also committed to acting on the values of Justice, Equity, Diversity, and Inclusion. We value and welcome applications from diverse experiences. We encourage you to apply even if you do not meet all the above-mentioned requirements. Should you require special accommodations due to a different set of abilities, please do not hesitate to contact us at karen@tapestrycapital.ca or at 416-977-5093 ext. 0. Tentative Selection Timeline - Application deadline: July 27, 2026 - Interview invites sent out: July 31, 2026 - Interviews held: week of August 4-10th - Reference check: week of August 10-13th - Offer sent out: week of August 20, 2026 - Start date: September 14, 2026